These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 31012939)

  • 1. Reporting of Multi-Arm Parallel-Group Randomized Trials: Extension of the CONSORT 2010 Statement.
    Juszczak E; Altman DG; Hopewell S; Schulz K
    JAMA; 2019 Apr; 321(16):1610-1620. PubMed ID: 31012939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The adaptive designs CONSORT extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    Trials; 2020 Jun; 21(1):528. PubMed ID: 32546273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Guidelines for Reporting Outcomes in Trial Reports: The CONSORT-Outcomes 2022 Extension.
    Butcher NJ; Monsour A; Mew EJ; Chan AW; Moher D; Mayo-Wilson E; Terwee CB; Chee-A-Tow A; Baba A; Gavin F; Grimshaw JM; Kelly LE; Saeed L; Thabane L; Askie L; Smith M; Farid-Kapadia M; Williamson PR; Szatmari P; Tugwell P; Golub RM; Monga S; Vohra S; Marlin S; Ungar WJ; Offringa M
    JAMA; 2022 Dec; 328(22):2252-2264. PubMed ID: 36511921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Adaptive designs CONSORT Extension (ACE) statement: a checklist with explanation and elaboration guideline for reporting randomised trials that use an adaptive design.
    Dimairo M; Pallmann P; Wason J; Todd S; Jaki T; Julious SA; Mander AP; Weir CJ; Koenig F; Walton MK; Nicholl JP; Coates E; Biggs K; Hamasaki T; Proschan MA; Scott JA; Ando Y; Hind D; Altman DG;
    BMJ; 2020 Jun; 369():m115. PubMed ID: 32554564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CONSORT 2010 statement: extension checklist for reporting within person randomised trials.
    Pandis N; Chung B; Scherer RW; Elbourne D; Altman DG
    Br J Dermatol; 2019 Mar; 180(3):534-552. PubMed ID: 30609010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CONSORT 2010 Explanation and Elaboration: Updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    J Clin Epidemiol; 2010 Aug; 63(8):e1-37. PubMed ID: 20346624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials.
    Moher D; Hopewell S; Schulz KF; Montori V; Gøtzsche PC; Devereaux PJ; Elbourne D; Egger M; Altman DG;
    Int J Surg; 2012; 10(1):28-55. PubMed ID: 22036893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):295-309. PubMed ID: 18283207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reporting of Factorial Randomized Trials: Extension of the CONSORT 2010 Statement.
    Kahan BC; Hall SS; Beller EM; Birchenall M; Chan AW; Elbourne D; Little P; Fletcher J; Golub RM; Goulao B; Hopewell S; Islam N; Zwarenstein M; Juszczak E; Montgomery AA
    JAMA; 2023 Dec; 330(21):2106-2114. PubMed ID: 38051324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement.
    Piaggio G; Elbourne DR; Altman DG; Pocock SJ; Evans SJ;
    JAMA; 2006 Mar; 295(10):1152-60. PubMed ID: 16522836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Randomized clinical trials (CONSORT)].
    Cobos-Carbó A;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():21-7. PubMed ID: 16464423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The CONSORT statement for cluster randomised trials].
    Campbell MK; Elbourne DR; Altman DG;
    Med Clin (Barc); 2005 Dec; 125 Suppl 1():28-31. PubMed ID: 16464424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration].
    Hopewel S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF; The CG
    Zhong Xi Yi Jie He Xue Bao; 2008 Mar; 6(3):221-32. PubMed ID: 18334138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.
    Piaggio G; Elbourne DR; Pocock SJ; Evans SJ; Altman DG;
    JAMA; 2012 Dec; 308(24):2594-604. PubMed ID: 23268518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration.
    Hopewell S; Clarke M; Moher D; Wager E; Middleton P; Altman DG; Schulz KF;
    PLoS Med; 2008 Jan; 5(1):e20. PubMed ID: 18215107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CONSORT Statement for Randomized Trials of Nonpharmacologic Treatments: A 2017 Update and a CONSORT Extension for Nonpharmacologic Trial Abstracts.
    Boutron I; Altman DG; Moher D; Schulz KF; Ravaud P;
    Ann Intern Med; 2017 Jul; 167(1):40-47. PubMed ID: 28630973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better reporting of harms in randomized trials: an extension of the CONSORT statement.
    Ioannidis JP; Evans SJ; Gøtzsche PC; O'Neill RT; Altman DG; Schulz K; Moher D;
    Ann Intern Med; 2004 Nov; 141(10):781-8. PubMed ID: 15545678
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments.
    Boutron I; Moher D; Altman DG; Schulz KF; Ravaud P;
    Ann Intern Med; 2008 Feb; 148(4):W60-6. PubMed ID: 18283201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Single-Case Reporting Guideline In Behavioural Interventions (SCRIBE) 2016 statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    Can J Occup Ther; 2016 Jun; 83(3):184-95. PubMed ID: 27231387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Single-Case Reporting Guideline In BEhavioural Interventions (SCRIBE) 2016 Statement.
    Tate RL; Perdices M; Rosenkoetter U; Shadish W; Vohra S; Barlow DH; Horner R; Kazdin A; Kratochwill T; McDonald S; Sampson M; Shamseer L; Togher L; Albin R; Backman C; Douglas J; Evans JJ; Gast D; Manolov R; Mitchell G; Nickels L; Nikles J; Ownsworth T; Rose M; Schmid CH; Wilson B
    J Clin Epidemiol; 2016 May; 73():142-52. PubMed ID: 27101888
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.